Key information relating to the preferential rights issue to be carried out by PCI Biotech Holding ASA NewsRonny SkuggedalAugust 24, 2018
PCI Biotech convenes an extraordinary general meeting to propose a fully underwritten Rights Issue of NOK 360 million NewsRonny SkuggedalAugust 24, 2018
Extension of preclinical research collaboration agreement with a top-10 large pharma company NewsRonny SkuggedalJune 15, 2018
PCI Biotech Holding ASA will be transferred to Oslo Børs from 27.04.2018 NewsRonny SkuggedalApril 27, 2018
Publication of prospectus summary for transfer of listing to Oslo Børs NewsRonny SkuggedalApril 25, 2018
